About Korro Bio

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms. Korro Bio was created to lead the field of RNA editing. The company is advancing a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. In 2018,

Repeat Founder
Company Highlights
Year Founded

2018

icon-altEmployees

106

Location (HQ)

USA

Since Last Funding

4 months

Monthly Website Visitors

6.2K

icon-altTotal Investment Amt

$300M

Last Funding Round

Post Ipo Equity

icon-altMoM Headcount Growth

0.95%

icon-altYoY Headcount Growth

1.92%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology

Biotechnology Research

Pharmaceutical